With the retirements of Ronald Fairman, MD, and M. Sean Grady, MD, looming in the not-so-distant future, a search was initiated to bring two new physician leaders to Penn Medicine: Two doctors with the reputation and acumen to step into the leadership of Penn Vascular Surgery & Endovascular Therapy and Penn Neurosurgery, respectively.
In late June, it was announced that Daniel Yoshor, MD, would be stepping into Dr. Grady’s position as Chair of the Department of Neurosurgery, and that Darren B. Schneider, MD, would be the new Chief of Penn Vascular Surgery and Endovascular Therapy.
Both highly regarded leaders in their individual fields, Drs. Yoshor and Schneider assumed their roles at Penn Medicine in July 2020.
Daniel Yoshor, MD
Dr. Yoshor was most recently the Marc J. Shapiro endowed professor and Chair of the Department of Neurosurgery at Baylor College of Medicine.
As a clinical neurosurgeon, he focuses on endoscopic pituitary and skull base surgery, as well as brain tumor and epilepsy surgery, and has one of the largest pituitary surgery practices in the nation.
A well-respected neuroscientist, as well, Dr. Yoshor has extensive experience in clinical brain mapping and the development and clinical implementation of novel neuro-technologies.
In addition to leading Penn Neurosurgery, he will also serve as Vice President of Clinical Integration and Innovation for the University of Pennsylvania Health System.
Dr. Yoshor will see patients at the Penn Neuroscience Center at the Perelman Center for Advanced Medicine.
Darren B. Schneider, MD
Dr. Schneider comes to Penn Medicine from New York Presbyterian Hospital – Weill Cornell Medicine.
As a surgeon, Dr. Schneider’s current clinical practice is focused on the treatment of complex aortic and iliac aneurysms and cerebrovascular disease. He also specializes in limb-threatening lower extremity arterial occlusive disease using advanced endovascular techniques.
Beyond his surgical practice, Dr. Schneider has made numerous contributions to clinical research. He was the national principal investigator for the pivotal, multi-center trial that led to FDA approval of an iliac branch stent graft for iliac artery aneurysms.
He is the principal investigator and sponsor of an ongoing, single-center, IDE study of endovascular repair of thoraco-abdominal aortic aneurysms using branched and fenestrated stent grafts, which he will continue at Penn Medicine.
Dr. Schneider will see patients at the Penn Heart and Vascular Center at the Perelman Center for Advanced Medicine.
Meet More New Penn Physician Colleagues
Drs. Yoshor and Schneider are among a distinguished group of recent additions at Penn Medicine whose profiles are available at the Penn Physician Announcements.